Skip to content

Dr. Dorien Leys

Active
Private limited companyfounded 2025active for less than a yearDolfijnstraat 92, 2018 Antwerpen, BelgiumKBO/BCE: BE 1029.781.890
Summary

Dr. Dorien Leys is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €15,048 and a net result of €12,048. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Activity not known1 site
Size
€21,106total assets 2025
Equity
€15,048
Profit
€12,048
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Too young for a bankruptcy probability
Structure
2025 accounts filed 27 days late
Signalsraises riskYoung company2025 accounts filed 27 days lateShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Without a bankruptcy probability: score from the figures alone
Financial strength
Strong
Solvency 96
equity 71.3% of total assets
Liquidity 88
short-term debt 28.7% · cash 86.0%
Profitability 100
return on assets 57.1%
Bankruptcy probability, 12 months

This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.

Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.48, above the usual 1.5; short-term debt: 28.7% and cash: 86% of total assets), and 28.7% of the assets are financed with debt and provisions.
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Two signals.
raises risk
raises risk · Young company
Founded in 2025, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years under a year 0 10 years
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
27 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: LEYS Dorien (director) ·…

Key points

  • Founded 11 months agofounded 29-10-2025 11 months View
  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €21,106 View

By topic

Financials

Financial year
2025
Total assets
€21,106
Profit
€12,048
Solvency
71.3%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Founded
29-10-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dr. Dorien Leys

What is the company number of Dr. Dorien Leys?
1029.781.890. In Belgium the VAT number is the company number with BE in front: BE 1029.781.890.
Where is Dr. Dorien Leys based?
The registered office is at Dolfijnstraat 92, 2018 Antwerpen.Company details
What is the legal form of Dr. Dorien Leys?
Private limited company (BV).
When was Dr. Dorien Leys founded?
On 29-10-2025.
Is Dr. Dorien Leys still active?
Yes, Dr. Dorien Leys is an active enterprise in the KBO register.
What is the turnover of Dr. Dorien Leys?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Dorien Leys profitable?
In financial year 2025, Dr. Dorien Leys made a profit of €12,048.
Where can I find the annual accounts of Dr. Dorien Leys?
Dr. Dorien Leys filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.